investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Overcoming acute, adaptive BRAF inhibitor resistance in melanoma
Roger S Lo
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Lisa G Aspinwall
Impact of Melanoma Genetic Testing on Health Cognitions and Prevention Behaviors
Melanoma of skin
Pathology
Jeffrey N Martin
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer - Uganda, Kenya, San Francisco
Melanoma of skin
Pathology
Xing Dai
Control of epithelial plasticity and differentiation in hair follicle stem/progenitor cells
Melanoma of skin
Pathology
Shengyu Yang
Store-Operated Calcium Entry in Tumor Invasion and Metastasis
Melanoma of skin
Pathology
Dave S B Hoon
Identification of Melanoma Brain Metastasis Tumor Biomarkers
Melanoma of skin
Pathology
Waldemar Priebe
Targeting Resistance to BRAF Inhibitors with WP760, a Melanoma Selective Agent
Melanoma of skin
Pathology
Craig Lee Slingluff
Melanoma Vaccine for Helper T Cells Combined with Targeted or Immune Therapies
Melanoma of skin
Pathology
Mark B Faries
Multicenter Selective Lymphadenectomy Trial (MSLT II) in Melanoma
Melanoma of skin
Pathology
John B Sunwoo
(PQB2) Identification of Tumor-Derived Activators of Anti-Cancer Immune Responses
Melanoma of skin
Pathology